- Home
- PBI vs KNSA Comparison
PBI vs KNSA Comparison
Compare PBI & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBI
- KNSA
- Stock Information
- Founded
- PBI 1920
- KNSA 2015
- Country
- PBI United States
- KNSA United Kingdom
- Employees
- PBI N/A
- KNSA N/A
- Industry
- PBI Office Equipment/Supplies/Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- PBI Miscellaneous
- KNSA Health Care
- Exchange
- PBI Nasdaq
- KNSA Nasdaq
- Market Cap
- PBI 2.2B
- KNSA 1.9B
- IPO Year
- PBI N/A
- KNSA 2018
- Fundamental
- Price
- PBI $11.66
- KNSA $33.41
- Analyst Decision
- PBI
- KNSA Strong Buy
- Analyst Count
- PBI 0
- KNSA 6
- Target Price
- PBI N/A
- KNSA $40.83
- AVG Volume (30 Days)
- PBI 4.3M
- KNSA 704.4K
- Earning Date
- PBI 07-30-2025
- KNSA 07-29-2025
- Dividend Yield
- PBI 2.42%
- KNSA N/A
- EPS Growth
- PBI N/A
- KNSA N/A
- EPS
- PBI N/A
- KNSA 0.07
- Revenue
- PBI $1,970,913,000.00
- KNSA $529,332,000.00
- Revenue This Year
- PBI N/A
- KNSA $37.21
- Revenue Next Year
- PBI $0.40
- KNSA $6.10
- P/E Ratio
- PBI N/A
- KNSA $502.82
- Revenue Growth
- PBI N/A
- KNSA 56.18
- 52 Week Low
- PBI $6.22
- KNSA $17.82
- 52 Week High
- PBI $13.11
- KNSA $33.98
- Technical
- Relative Strength Index (RSI)
- PBI 53.15
- KNSA 67.33
- Support Level
- PBI $10.92
- KNSA $31.78
- Resistance Level
- PBI $11.67
- KNSA $33.68
- Average True Range (ATR)
- PBI 0.48
- KNSA 1.23
- MACD
- PBI -0.07
- KNSA 0.27
- Stochastic Oscillator
- PBI 46.88
- KNSA 91.12
About PBI Pitney Bowes Inc.
Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal worksharing discounts. It derives maximum revenue from SendTech Solutions.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.